Coverage Uncertainty and Cancer Diagnosis: Insights from Dr. Mark Schlesinger
What happens when patients don't trust their health insurance to cover necessary care? According to new preliminary research from Yale University and partner institutions, uncertainty doesn't just affect how patients pay for care; it affects whether and when they seek care at all.
Mark Schlesinger, PhD, professor of health policy at Yale University and the principal investigator on the AcademyHealth Project "Coverage Uncertainty and the Sources of Diagnostic Delay in Cancer Treatment," sat down with UCSF CODEX's Learning Hub Faculty Lead Anjana Sharma, MD, MAS, to discuss how insurance doubt shapes patient behavior and healthcare outcomes. Working alongside researchers from Johns Hopkins University (Kathy McDonald, PhD, MM/MBA, Kelly Gleason, PhD, RN, FAAN, and Christina Yuan, MPH, PhD) and the University of Wisconsin-Madison (Rachel Grob, MA, PhD, and Jane Evered, PhD, RN), Dr. Schlesinger’s team surveyed 1,300 people and collected patient narratives to understand the relationship between insurance trust and diagnostic timing.
Below, watch the full conversation and check out the Q&A highlights to explore racial and ethnic disparities, their research methodology combining objective measures with patient narratives, and preliminary findings from the patient perspective.
Support for this research project was provided by AcademyHealth’s Pre-hospital Diagnostic Delay program and the Gordon and Betty Moore Foundation. The views expressed here do not necessarily reflect the views of either organization.
__
Q&A Highlights
1. What is coverage uncertainty?
“We all know if we've gone through a serious illness or had that in our family or with our loved ones that health insurance is a contract that promises to pay for medical expenses, but it doesn't pay for all medical expenses. It promises to pay for those that the insurance company deems to be medically necessary. What happens is a lot of people discover if they have a serious illness like cancer that not all the things they or their doctor think are medically necessary are deemed that by the insurance firm.”
2. How does coverage uncertainty impact cancer diagnosis?
"Out of the 1,300 people surveyed [from a representative population from the National Opinion Research Corporation (NORC)], we asked them about their interactions with their health insurance, and people told us that before they began the search for the cancer diagnosis that about a third of them didn't exactly trust their health insurance. That is, they worried about what it would cover, they'd experienced in the previous year some unexpected medical expense, and so they went into the cancer diagnosis being just a little doubtful about what it would mean for their financial well-being.”
3. What is the main finding of the project so far?
“People who start into the diagnostic experience [uncertain] are much more likely to report diagnostic delays, and much more likely to report timing of diagnosis that takes a longer period of time than people who went into it being more sure and comfortable with their insurance coverage. More specifically, in households that have no coverage uncertainty going into the cancer diagnosis, about 30% report a diagnostic delay. In households that reported coverage uncertainty before the search for the cancer diagnosis, about 60% reported a diagnostic delay. ... if you don't trust your insurance, you're going to put things off even longer, because if you don't have to run up a bill, it would be all the better, and so people wait until they're absolutely certain they really need this consultation with a doctor before they go, and that just adds time.”
4. What are the implications of this research?
“Perceiving that you had a delay had all kinds of subsequent sequalae or consequences. When people go through a cancer experience, and they feel like they have not had a delayed diagnosis, about 10% report that something in that experience caused them to lose trust in the healthcare system. For people who reported a delay, about 40% lose trust as part, so four times the loss of trust, equally big increments in terms of emotional harms being reported. Cancer is scary. There will always be hard emotions, even when things go quickly. And even when outcomes are good. But having a delayed diagnosis significantly increased those emotional harms. Even a perception of delay matters.”
5. What are you hearing from patients so far?
“We have to help people both feel and have health insurance that is more reliable for them, so they don't have these doubts because having doubts in and of itself disrupts the diagnostic process. And for the group of people who have their cancer journey kind of initiated by their own recognition of symptoms, of course, one of the things we see over and over again is people will say, oh, I should have gotten into the doctor sooner. I didn't know, I wasn't sure, I put it off, because a lot of the symptoms that are being reported, even in the cases of long delay, are kind of undifferentiated, feeling fatigued, feeling pain. So, it's just not clear exactly what's going on. It's easy to say, maybe I'll feel better next month, and it's easy to put it off, and so you have a lot of people, kind of. Regretting their own initiation of care taking too long. Of course, on top of that, if you don't trust your insurance, you're going to put things off even longer, because if you don't have to run up a bill, it would be all the better, and so people wait until they're absolutely certain they really need this consultation with a doctor before they go, and that just adds time.”
Bonus Question: What’s your message for other researchers?
“In much of the research that's been done on trying to improve diagnosis, [to] get to diagnostic excellence [and] try to decrease the amount of diagnostic delay, researchers have been a little bit cautious about drawing on patient experience, more so than in many other aspects of healthcare. And one of the things that we've been doing as part of that larger research team I've talked about earlier is to try to make clear that patients are both a reliable source of information that you can't get for other sources, like how much do you trust your health insurance. You can't get that from the medical record. You can only get that for talking to patients, and they are a reasonably reliable source of information about things, about what happens when things go wrong, there are delays in diagnosis, how that impacts them, how it changes their subsequent healthcare behavior or healthcare expectations.”
Next steps
Dr. Schlesinger and his team are analyzing patient narratives collected from talking to cancer patients and their families and finding actionable information on how to reduce problems leading to diagnostic delays in the future.
